2FIRSTS and Russian Academy of Sciences Discuss E-cigarette Science Research

Apr.10.2023
2FIRSTS and Russian Academy of Sciences Discuss E-cigarette Science Research
Chinese and Russian e-cigarette experts discuss research, regulation, and trade in Moscow on April 7, 2023.

On April 7th, 2023, CEO of 2FIRSTS, Tong Zhao, and Vice President of the Russian region, Minghao Xu, met with senior researcher at the Russian Academy of Sciences, Menshov Valery, and Deputy Director of the Emanuel Institute of Biochemical Physics, Alexei V. Trofimov, in Moscow to discuss scientific research in the field of electronic cigarettes.


From left to right, the individuals in the photo are: Men'shchikov Valery, a Senior Researcher at the Russian Academy of Sciences; Zhao Tong, CEO of 2FIRSTS; Xu Minghao, Vice President of 2FIRSTS in the Russian region; and Aleksey V. Trofimov, Deputy Director of the Emmanuel Institute for Biochemical Physics. Image source: 2FIRSTS Moscow News Center.


During the exchange meeting, representatives from both sides engaged in in-depth discussions on topics such as the regulation of electronic cigarettes, product standards, and electronic cigarette trade between China and Russia. 2FIRSTS presented to experts from the Russian Academy of Sciences the global trends in compliant development of electronic cigarettes, China's electronic cigarette regulatory policies, and the progress of Chinese companies in electronic cigarette research. The Russian Academy of Sciences experts, in turn, briefed 2FIRSTS on the current state and challenges faced in electronic cigarette research.


Experts from the Russian Academy of Sciences expressed their keen interest in collaborating with the Chinese e-cigarette industry on scientific research. In-depth studies on core topics such as nicotine will aid in the development of regulatory policies and ensure consumer protection.


CEO Zhao Tong of 2FIRSTS announced that 2FIRSTS, as a global technology media and think tank focused on atomization, will leverage its global resources to support research exchange and collaboration between Chinese and Russian enterprises and scientific research institutions, in order to promote high-quality development of Sino-Russian trade.


Global monthly report on electronic cigarette regulation (Russian edition) | Image source: 2FIRSTS Russia Moscow News Center.


During the meeting, 2FIRSTS presented a monthly report titled "Global Electronic Cigarette Regulatory Monthly Report (Russian version)" to the experts from the Russian Academy of Sciences. The report covers the regulatory situation, policy trends, industry trends and other related topics of major electronic cigarette markets worldwide. The Russian experts highly valued the report's content and its importance.


Both sides also discussed topics such as smoke-free products.


At the end of the meeting, both parties unanimously acknowledged the potential and value of cooperation in scientific research on electronic cigarettes. They agreed to work together and make efforts to accelerate the implementation of specific cooperation projects.


Russian Academy of Sciences | Image Source: 2FIRSTS Moscow News Center


The Russian Academy of Sciences (RAS) is the national scientific institution of the Russian Federation and is the country's largest center for fundamental scientific research. Its predecessor was the Soviet Academy of Sciences (1925). The primary goal of RAS is to organize and conduct basic and applied scientific research on issues related to natural, technical, humanistic, and social sciences, with the aim of acquiring new knowledge about the laws of nature, society, and human development.


As the highest academic institution in Russia, the Russian Academy of Sciences participates in coordinating basic research for scientific organizations and higher education institutions with the support of the national budget.


Since 1925, RAS has had 15 Nobel Prize laureates. The Russian Academy of Sciences has a legal status as a federal state budgetary institution.


Introduction to Shenzhen 2FIRSTS Technology Co., Ltd.


2FIRSTS Technology Co., Ltd. (hereinafter referred to as "2FIRSTS") was established in 2021 and is a leading misting technology media and think tank globally. With its global resource advantage and professional team, 2FIRSTS provides international media and consulting services for the global misting industry, promoting its compliance and high-quality development worldwide. The company also aims to drive a win-win situation for various stakeholders, including consumers' interests, government tax revenues, and social responsibility, by advancing misting technology and industry.


2FIRSTS owns the website 2firsts.com, which has versions in Chinese, English, and Russian. The company has created a global network of information and services, with media centers located in Shenzhen, Washington D.C., London, Moscow, Indonesia, and other parts of the world. This has allowed for a strong connection from the Chinese e-cigarette supply chain to the global consumer market.


The founding team of 2FIRSTS entered the tobacco industry in 2015 and has conducted thorough research in both traditional and new forms of tobacco. The company has established close partnerships with international tobacco companies, Chinese supply chain businesses, regulatory agencies, industry non-profit organizations, and media outlets.


The following information is from the official website of the Russian Academy of Sciences:


Alexei Vladimir Trofimov


Vice Director of the Emanuel Institute of Biochemical Physics at the Russian Academy of Sciences.


PhD in Physics and Mathematics; PhD in Chemistry;


From September 1982 to June 1988, he/she studied at the Moscow Institute of Physics and Technology.


From March 1994 to December 2002, worked at the Institute of Organic Chemistry at the University of Würzburg in Germany.


Since April 1996, he/she has been employed at the Institute of Biochemical Physics of the Russian Academy of Sciences.


Research:


In December 2020, a study titled "The effects of nicotine on heart rate variability through various delivery systems" was published.


In April of 2021, a study titled "Changes in the Antioxidant Properties of Tar in Tobacco Smoke during Metabolism: A Chemiluminescence Modeling Study" was published.


Men Shaofu Valeri


Senior researcher at the Institute of Biochemical Physics of the Russian Academy of Sciences.


Candidate for a chemistry science Ph.D. and academian.


Study:


Diversity of Functions of Liposoluble Antioxidants in Microbial Growth Environments and Cells


References:


1. Information on Alexei Vladimir Trofimov


Alexei Vladimir Trofimov Information 2.


Information on Men Shao Fu Valerie


The official website of the Russian Academy of Sciences.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23